Propelled by NIPT, China Moves to the Fore in NGS Assays

Propelled by NIPT, China Moves to the Fore in NGS Assays

China is playing an increasingly significant role not only in the IVD industry, but global clinical markets. Kalorama Information offers comprehensive subject reports that variously treat the Chinese IVD , global cancer diagnostics , prenatal testing , circulating tumor cells (CTCs) , and next-generation sequencing (NGS) markets.

The stakes are high for clinical next-generation sequencing (NGS) platform vendors in the Chinese market. In 2014, the Chinese Food & Drug Administration (CFDA; SFDA)...


Theranos Aims Big Outside of LDTs’ Esoteric Pigeonhole

Theranos Aims Big Outside of LDTs’ Esoteric Pigeonhole

More information regarding the clinical lab testing or clinical lab services market can be found in Kalorama Information’s Clinical Lab Services Market (Growth Opportunities, Competitive Analysis and Competitor Profiles). Kalorama also offers specialty market coverage of retail clinics with Retail Clinics 2015: Growth of Stores, Consumer Opinion, Leading Competitors, Sales of Products to Clinics (Diagnostic Tests, Pharmaceuticals, Vaccines), Clinic Sales Forecasts and Trends.

Carefully watched...


Biopharma Embraces a Microbrewery Mindset with Single-Use Bioreactors

Biopharma Embraces a Microbrewery Mindset with Single-Use Bioreactors

This blog post serves as an introduction to the bioreactors market and an impactful biopharma industry trend. More information regarding the market for single-use bioreactors can be found in Kalorama Information’s recently published The Worldwide Market for Bioreactors.

Fermentation is serious business, whether its in the biopharmaceuticals or beverage industry. Similarities in the production processes of biosimilar drugs and beers can be spotted readily, but the comparison usually ends there ...


Microbiology Diagnostics Is Alive and Well - Beckman Coulter Adds to its Core Testing Solutions

Microbiology Diagnostics Is Alive and Well - Beckman Coulter Adds to its Core Testing Solutions

The following analysis is derived from Kalorama Information’s upcoming report on the global infectious disease test market. The report’s prior edition, The Worldwide Market for Infectious Disease Diagnostic Tests , is also available.

This post discusses the potentially undervalued move by Beckman Coulter to enter the market for traditional microbiology diagnostics or ID/AST systems at a time when many mid-sized and major IVD companies have focused on molecular diagnostic methods. Similarly aus...


Despite Slowdown Fears, No Change in China IVD Forecast

Despite Slowdown Fears, No Change in China IVD Forecast

Despite a growing concern about a slowdown in the Chinese economy, Kalorama Information does not see a lower estimate for the IVD industry. A few months ago we estimated that in 2014, the IVD market in China was $2.2 billion and is expected to show annual growth of 14.1% to reach $4.2 billion in 2019. We still see that estimate as most likely. The breakneck expansion of the past has tempered, underlying characteristics of the Chinese market - large population in need of healthcare will support c...